6 investors discuss why AI is more than just a buzzword in biotech • TechCrunch
As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. That’s why we weren’t very surprised...
biotech
6 investors discuss why AI is more than just a buzzword in biotech • TechCrunch
As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. That’s why we weren’t very surprised...
As AI pervades biotech, what are investors looking for in 2023? • TechCrunch
Silicon Valley law firm Cooley recently reported that it “handled 298 disclosable venture capital financings for Q3 2022, representing $8.1...
